01 3Avalox/Avelox
02 1AvaloxTM/AveloxTM
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2015 Revenue in Millions : 419
2014 Revenue in Millions : 417
Growth (%) : 0%
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2014 Revenue in Millions : -10.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 413
2016 Revenue in Millions : 438
Growth (%) : -6
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 374
2015 Revenue in Millions : 402
Growth (%) : -7
LOOKING FOR A SUPPLIER?